Ignite Creation Date:
2025-12-24 @ 10:52 PM
Ignite Modification Date:
2026-02-07 @ 11:14 AM
Study NCT ID:
NCT02711969
Status:
COMPLETED
Last Update Posted:
2022-07-22
First Post:
2016-02-26
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Apatinib Mesylate (YN968D1) 1,000mg in Gastric Cancer Patient Failed to Standard Treatment
Sponsor:
Bukwang Pharmaceutical
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
BK-AM-GC102
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None